Entry Point Capital, LLC Fulgent Genetics, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding FLGT
# of Institutions
195Shares Held
15.3MCall Options Held
1.07MPut Options Held
27.9K-
Black Rock Inc. New York, NY3.92MShares$84 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$30.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.22MShares$26 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny959KShares$20.5 Million0.01% of portfolio
-
Park West Asset Management LLC Larkspur, CA833KShares$17.8 Million1.3% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $648M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...